Yesterday, a jury ordered Monsanto to pay more than $2 billion to a couple in California who claim they got non-Hodgkin’s lymphoma from using the company’s popular weed killer Roundup.
The cancerous relationship between Monsanto and EPA
Glyphosate, a key ingredient of Monsanto’s herbicide Roundup, was ruled a “probable carcinogen” by the World Health Organization in 2015. However, the US Environmental Protection Agency sided with Monsanto and declared in April that the weed killer is safe. Somebody’s lying, right?
Well, you guessed right. It’s EPA and Monsanto. In 2017, Jess Rowland, the EPA official who was in charge of evaluating the risk of cancer from Roundup, was caught on the phone bragging to a Monsanto exec how he could kill an investigation into Roundup by another agency.
Monsanto Quentin Miller’d the toxicology reports
The company has also been accused of hiring ghostwriters to make up toxicology reports that were submitted to an EPA committee so that glyphosate wouldn’t be ruled as carcinogenic. Spooky.
Surgical summer awaits for Monsanto?
The jury in San Francisco, however, didn’t buy Monsanto’s claims and ordered the company to pay up. Stock price of Bayer, the German giant that bought Monsanto for $66 billion in 2016, fell 2.25% yesterday following the court’s decision. The company has now lost over 44% of its value since the merger.
It ain’t over for Monsanto – there are now more than 13,000 pending cases against the company lined up in the US.